Market Cap
$45.6B
MDLN
Medline Inc.
$35.38 ▲ +1.26%
Prev close $34.94Market cap$45.6B
ConsensusBuy
12-mo target$44.54 (+25.9%)
▲ Bullish
Analyst conviction 8/10
Insider Selling Cluster (3 insiders)High Impact Filing (7/10)43 New Institutional Positions7 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on MDLN right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Strong Buy (79%)
Inst. Holders
50 funds
Inst. Value
$23.9B
Inst. Activity
43 buys / 7 sells
Insider Activity
$0.00 buy / $3.8B sell
Insider Net $
-$3.8B
SEC Reports
14
Press Releases
4
Price chart 30d -2.5%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: MDLN — 75.9% short (3.3M / 4.4M)
Short: 3,330,915 | Exempt: 130 | TRF Vol: 4,388,433 | Short Ratio: 75.9% | Off-exchange volume (dark
Aug 19, 2026 Insider
Boyle James M was granted 764,252 shares
Chief Executive Officer
Aug 19, 2026 Insider
Miller Stephen L was granted 87,667 shares
Chief Operating Officer
Aug 14, 2026 Insider
Aug 5, 2026 SEC GIC Private Ltd sold 100,000 shares
10%+ Owner @ $35.80 ($3.6M)
Medline reported Q2 2026 adjusted EPS of $0.50, beating consensus of $0.32 by 56%, and revenue of $7.69B, beating $7.51B
PRESS-RELEASE — Impact 6/10
Medline reported Q2 2026 adjusted EPS of $0.50, beating consensus of $0.32 by 56%, and revenue of $7.69B, beating $7.51B
8-K — Impact 6/10
Medline Inc. (MDLN) disclosed the upcoming retirement of COO Stephen L. Miller, effective August 30, 2026, for health re
8-K — Impact 2/10
Jun 30, 2026 Inst.
FMR LLC — ADD
46,963,203 shares ($1.9B)
Analyst ratings buy % -2.5%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
79% rate it Buy or better · 34 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 25, 2026 | UBS | MAINTAIN | Buy | 55% |
| Aug 27, 2026 | BTIG | REITERATE | Buy | 53% |
| Aug 12, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Aug 11, 2026 | Tigress Financial | MAINTAIN | Buy | 59% |
| Aug 11, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Aug 10, 2026 | TD Cowen | MAINTAIN | Buy | 56% |
| Aug 6, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Aug 6, 2026 | Truist Securities | MAINTAIN | Buy | 55% |
| Aug 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | 59% |
| Aug 6, 2026 | Stifel | MAINTAIN | Buy | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 12 | 15 | 7 | 0 | 0 | 79% | |
| Aug 1, 2026 | 12 | 15 | 7 | 0 | 0 | 79% | |
| Jul 1, 2026 | 12 | 16 | 7 | 0 | 0 | 80% | |
| Jun 1, 2026 | 12 | 16 | 7 | 0 | 0 | 80% | |
| May 1, 2026 | 12 | 15 | 7 | 0 | 0 | 79% | |
| Apr 1, 2026 | 12 | 15 | 6 | 0 | 0 | 82% | |
| Mar 1, 2026 | 12 | 16 | 6 | 0 | 0 | 82% | |
| Feb 1, 2026 | 12 | 13 | 6 | 0 | 0 | 81% |
Price targets
Where 26 covering analysts think MDLN trades over the next 12 months.
$44.54 +25.9% upside Strong Buy
Current$35.38 Low$34.00 Median$45.00 High$55.00 26 analysts
$34.00$55.00
Analyst rating Buy· 1.6/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
14 SEC filing reports analyzed · 0 bullish, 3 bearish, 4 mixed, 7 neutral · avg impact 5.1/10.Plus 4 press releases.
MIXEDPRESS-RELEASE6/10
Medline reported Q2 2026 adjusted EPS of $0.50, beating consensus of $0.32 by 56%, and revenue of $7
Aug 5, 2026
MIXED8-K6/10
Medline reported Q2 2026 adjusted EPS of $0.50, beating consensus of $0.32 by 56%, and revenue of $7
Aug 5, 2026
NEUTRAL8-K2/10
Medline Inc. (MDLN) disclosed the upcoming retirement of COO Stephen L. Miller, effective August 30,
Jul 9, 2026
NEUTRALINST-CLUSTER3/10
5 mega-passive institutional investors (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley)
Jun 11, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: MDLN — 75.9% short (3.3M / 4.4M)
Short: 3,330,915 | Exempt: 130 | TRF Vol: 4,388,433 | Short Ratio: 75.9% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
short_volume
Short Volume: MDLN — 69.0% short (2.0M / 2.9M)
Short: 2,013,735 | Exempt: 0 | TRF Vol: 2,918,461 | Short Ratio: 69.0% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: MDLN — 82.4% short (2.2M / 2.6M)
Short: 2,181,237 | Exempt: 0 | TRF Vol: 2,646,904 | Short Ratio: 82.4% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: MDLN — 83.2% short (2.3M / 2.8M)
Short: 2,341,264 | Exempt: 12 | TRF Vol: 2,812,932 | Short Ratio: 83.2% | Off-exchange volume (dark pool + OTC)
Sep 25, 2026
short_volume
Short Volume: MDLN — 84.7% short (2.0M / 2.3M)
Short: 1,968,493 | Exempt: 1,146 | TRF Vol: 2,322,712 | Short Ratio: 84.7% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.35 | $0.28–$0.47 | — | -0.2% | 1↑ 19↓ | $7.7B | 23 |
| Next Q | $0.40 | $0.30–$0.53 | 29.9% | -0.2% | 0↑ 19↓ | $8.5B | 22 |
| Current FY | $1.55 | $1.36–$1.82 | 17.5% | -1.4% | 14↑ 3↓ | $31.2B | 18 |
| Next FY | $1.58 | $1.40–$1.83 | 1.6% | -0.3% | 4↑ 18↓ | $33.7B | 25 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.346 | — |
| 7d ago | $0.347 | -0.001 |
| 30d ago | $0.347 | -0.001 |
| 60d ago | $0.387 | -0.041 |
| 90d ago | $0.387 | -0.041 |
Institutional ownership
Which big funds own MDLN (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $23.9B total value (606,033,122 shares) as of 2026-Q2. Top holders: Erste, Carlyle, FMR. Net buying activity: 43 institutions added/increased vs 7 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| Erste Asset Management GmbH | 0 | $0.00 | 0.0% | — |
| Carlyle Group Inc. | 187,083,713 | $7.4B | 30.8% | — |
| FMR LLC | 46,963,203 | $1.9B | 7.7% | ADD +28.5% |
| Capital Research Global Investors | 39,963,790 | $1.6B | 6.6% | ADD +72.5% |
| Invesco Ltd. | 38,346,937 | $1.5B | 6.3% | — |
| BlackRock, Inc. | 26,393,587 | $1.0B | 4.4% | ADD +56.0% |
| MORGAN STANLEY | 21,605,662 | $852.1M | 3.6% | ADD +37.6% |
| LONE PINE CAPITAL LLC | 20,968,367 | $827.0M | 3.5% | ADD +77.9% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 19,888,806 | $787.1M | 3.3% | ADD +71.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 17,816,057 | $702.7M | 2.9% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| FMR LLC | ADD | 36,556,201 | 46,963,203 | +28.5% | $1.9B |
| Capital Research Global Investors | ADD | 23,161,670 | 39,963,790 | +72.5% | $1.6B |
| BlackRock, Inc. | ADD | 16,923,660 | 26,393,587 | +56.0% | $1.0B |
| MORGAN STANLEY | ADD | 15,702,903 | 21,605,662 | +37.6% | $852.1M |
| LONE PINE CAPITAL LLC | ADD | 11,789,156 | 20,968,367 | +77.9% | $827.0M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | ADD | 11,569,316 | 19,888,806 | +71.9% | $787.1M |
| Egerton Capital (UK) LLP | DOUBLED | 4,365,802 | 16,470,884 | +277.3% | $649.6M |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | DOUBLED | 4,384,729 | 11,956,905 | +172.7% | $471.6M |
| NORGES BANK | NEW | — | 8,475,413 | — | $334.3M |
| STATE STREET CORP | ADD | 4,822,383 | 8,447,035 | +75.2% | $333.2M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
18 insiders, 50 transactions. Net -$3.8B — $0.00 bought, $3.8B sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Boyle James M | Chief Executive Officer | AWARD | 764,252 | — | — |
| Aug 19, 2026 | Miller Stephen L | Chief Operating Officer | AWARD | 87,667 | — | — |
| Aug 14, 2026 | GIC Private Ltd | 10%+ Owner | SELL | 100,000 | $35.80 | $3.6M |
| Aug 13, 2026 | GIC Private Ltd | 10%+ Owner | SELL | 1,500,000 | $35.80 | $53.7M |
| Aug 7, 2026 | GIC Private Ltd | 10%+ Owner | SELL | 590,284 | $35.58 | $21.0M |
| Aug 6, 2026 | GIC Private Ltd | 10%+ Owner | SELL | 271,994 | $35.33 | $9.6M |
| Aug 6, 2026 | Mozart Holdco, Inc. | 10%+ Owner | CONVERT | 500,000 | — | — |
| Aug 6, 2026 | Mozart Holdco, Inc. | 10%+ Owner | CONVERT | 500,000 | — | — |
| Aug 6, 2026 | Mozart Holdco, Inc. | 10%+ Owner | J | 500,000 | — | — |
| Aug 5, 2026 | GIC Private Ltd | 10%+ Owner | SELL | 1,710,907 | $35.46 | $60.7M |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for MDLN.
Shares short
41,309,561
Settlement Sep 15, 2026
Change vs prior
+4.6%
Semi-monthly cycle
Days to cover
6.4
At avg daily volume
Of shares outstanding
≈3.1%
Estimate — not % of float
All MDLN filing & press-release reports (18)
- PRESS-RELEASE reportAug 5, 2026
- 8-K reportAug 5, 2026
- 8-K reportJul 9, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportJun 2, 2026
- CLUSTER reportJun 1, 2026
- CLUSTER reportJun 1, 2026
- EFFECT reportMay 22, 2026
- PRESS-RELEASE reportMay 22, 2026
- PRESS-RELEASE reportMay 20, 2026
- 8-K reportMay 6, 2026
- PRESS-RELEASE reportMay 6, 2026
- DEFA14A reportApr 23, 2026
- 424B4 reportMar 6, 2026
- PRESS-RELEASE reportMar 5, 2026
- PRESS-RELEASE reportMar 3, 2026
- S-1 reportMar 3, 2026
- 8-K reportFeb 25, 2026